Contact
Please use this form to send email to PR contact of this press release:
High-Mobility Group Nucleosomal-Binding Domain 2: A Prognostic Indicator and A New Therapeutic Target for Gliomas
TO:
Genes & Diseases Editorial Office
Genes & Diseases
+86 23 6571 4691